Brian Varnum - Apr 13, 2022 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
President and CEO
Signature
/s/ Todd R. Patrick, attorney-in-fact
Stock symbol
ARMP
Transactions as of
Apr 13, 2022
Transactions value $
$0
Form type
4
Date filed
4/15/2022, 03:46 PM
Previous filing
Aug 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +240K $0.00 240K Apr 13, 2022 Common Stock 240K $5.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant.